Skip to main content
. 2020 Jul 16;8(11):2245–2250. doi: 10.1002/ccr3.3132

Table 3.

Ganglioside antibody results

Antibody GBS total MFv total Total
GD1a 3 (33.3%) 2 (25%) 5 (29.4%)
GD1b 5 (55.5%) 2 (25%) 7 (41.2%)
GQ1b 2 (22.2%) 4 (50%) 6 (35.3%)
AsialoGM1 2 (22.2%) 1 (12.5%) 3 (17.6%)
GM1 4 (44.4%) 0 4 (23.5%)
GM2 2 (22.2%) 0 2 (11.8%)

Summary of ganglioside antibody panel for 17 patients diagnosed with GBS and MFv in Adventist Health White Memorial (AHWM) and California Hospital Medical Center (CHMC) in 2015.